Zobrazeno 1 - 10
of 14
pro vyhledávání: '"George, Rochester"'
Autor:
Antonio Paredes, Minh Huynh, Aaron Heuser, Mike Trinh, Hautahi Kingi, George Rochester, Li-An Daniel Wang, T. Shafer
Publikováno v:
Social Network Analysis and Mining. 10
We develop an algorithm to compute exact solutions to the influence maximization problem using concepts from reverse influence sampling (RIS). We implement the algorithm using GPU resources to evaluate the empirical accuracy of theoretically guarante
Autor:
Tricia L. Johnson, Jeannie H. Jeong-Im, C. George Rochester, Matthew J. Walters, Bryan A. Hearn, Getie Zewdie, Yan S. Ding, Matthew R. Holman, Clifford H. Watson
Publikováno v:
Tob Regul Sci
OBJECTIVES: Correlations are made between mainstream cigarette smoke deliveries of individual PAHs over multiple years. Average overall PAH deliveries in mainstream cigarette smoke by study year, mentholation, ring size, and manufacturer are compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a295cea557f30afffaf4e16a5e5a3060
https://europepmc.org/articles/PMC7884091/
https://europepmc.org/articles/PMC7884091/
Autor:
Zhiheng Xu, G. Steven Condrey, Robert Ball, Ella Smith, Jonathan G. Levine, Taxiarchis Botsis, Ana Szarfman, Stuart J. Chirtel, Carlos Bell, David Martin, Taiye Oladipo, George Rochester, Taha A. Kass-Hout, Keith Burkhart, Hui-Lee Wong, Susan J. Bright-Ponte, Deborah Sholtes, Rene O'Neill, Khaled Bouri, John D. Baker, Hongying Jiang, Roselie A. Bright, James J. Chen, Ross W. Filice, Joseph M. Tonning, Antonio Paredes, Hesha J. Duggirala, Lee Anne Palmer, Henry Francis, Marc Boyer
Publikováno v:
Journal of the American Medical Informatics Association. 23:428-434
Objectives This article summarizes past and current data mining activities at the United States Food and Drug Administration (FDA). Target audience We address data miners in all sectors, anyone interested in the safety of products regulated by the FD
Autor:
David Ohlssen, Fanni Natanegara, Nelson Kinnersley, George Rochester, John W. Seaman, Cory R. Heilmann, Beat Neuenschwander
Publikováno v:
Pharmaceutical Statistics. 13:3-12
Bayesian applications in medical product development have recently gained popularity. Despite many advances in Bayesian methodology and computations, increase in application across the various areas of medical product development has been modest. The
Autor:
Laura A. Governale, Andrew D. Mosholder, George Rochester, Yute Wu, Tarek A. Hammad, Carol A. Pamer, Sigal Kaplan
Publikováno v:
Pharmacoepidemiology and Drug Safety. 19:158-174
Purpose To determine if paroxetine versus non-paroxetine selective serotonin reuptake inhibitors (SSRIs) prescribing changed after the June 2003 FDA Paroxetine Public Health Advisory (PPHA) and if antidepressant and antipsychotic prescribing changed
Autor:
Ernest S Harpur, Devan V. Mehrotra, Eileen C King, Manfred Oster, Jesse A. Berlin, Robert C Schriver, Juergen Kuebler, David B. Hall, Hongliang Shi, Zhengqing Li, Brenda J. Crowe, Jane B Porter, Nancy C. Santanello, Douglas J. Watson, H. Amy Xia, George Rochester, Stephen L Lin
Publikováno v:
Clinical Trials. 6:430-440
Background The Safety Planning, Evaluation and Reporting Team (SPERT) was formed in 2006 by the Pharmaceutical Research and Manufacturers of America. Purpose SPERT’s goal was to propose a pharmaceutical industry standard for safety planning, data c
Autor:
George A. Neyarapally, Solomon Iyasu, Simone P. Pinheiro, George Rochester, Gerald J. Dal Pan, Tarek A. Hammad
Publikováno v:
Clinical trials (London, England). 10(3)
Background Due to the sparse nature of serious drug-related adverse events (AEs), meta-analyses combining data from several randomized controlled trials (RCTs) to evaluate drug safety issues are increasingly being conducted and published, influencing
Autor:
Yu-te Wu, Charles K. Cooper, Sumathi Nambiar, Yan Wang, Thamban Valappil, Cynthia Kornegay, George Rochester, Peter W. Kim
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 51(4)
Background On the basis of meta-analyses, concern has been raised regarding a possible signal of increased mortality associated with the use of cefepime versus other beta-lactam antibiotics. To further investigate this possible signal, we accessed fi
Autor:
Carol A, Pamer, Tarek A, Hammad, Yu-Te, Wu, Sigal, Kaplan, George, Rochester, Laura, Governale, Andrew D, Mosholder
Publikováno v:
Pharmacoepidemiology and drug safety. 19(2)
To determine if paroxetine versus non-paroxetine selective serotonin reuptake inhibitors (SSRIs) prescribing changed after the June 2003 FDA Paroxetine Public Health Advisory (PPHA) and if antidepressant and antipsychotic prescribing changed after th
Autor:
Marc Stone, Tarek A. Hammad, P Chris Holland, M Lisa Jones, Thomas Laughren, George Rochester, Alice Hughes, Robert Temple, Mark Levenson
Publikováno v:
The BMJ
Objective To examine the risk of suicidal behaviour within clinical trials of antidepressants in adults. Design Meta-analysis of 372 double blind randomised placebo controlled trials. Setting Drug development programmes for any indication in adults.